🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

The Government Won't Let Huawei Enforce U.S. Patents

Published 06/18/2019, 03:56 AM
Updated 07/09/2023, 06:31 AM
VZ
-
TMUS
-
USM
-
GLIBA
-
GOGO
-

Huawei may be looking for an opportunity to talk to government officials, but the government is clearly not in the mood. Not only have officials made it clear that there are going to be no negotiations with the company, but it has also indicated that it will go to lengths to see that the company doesn’t create any mischief.

So when Huawei said Verizon (NYSE:VZ) owes it a billion dollars for infringement of 230 patents, Republican Senator Marco Rubio tweeted that the action was an “attempt by (Huawei) to retaliate against the U.S. by setting the stage for baseless, but costly, patent claims.”

He even followed that up with a proposed amendment to the National Defense Authorization Act (NDAA) that was earlier invoked to prevent federal purchases of Huawei products on the basis of national security concerns. The NDAA sets the broad policies for spending by the Department of Defense.

The current amendment seeks to prevent companies like Huawei that are placed on specified U.S. watch lists, from seeking legal resolution or damages in any U.S. court with respect to U.S. patents. While it still hasn’t been signed into law, this could happen quickly since both Republicans and Democrats generally agree on China concerns.

Huawei has of late been amassing U.S. patents, so the company may have been waiting to start claiming its rights anyway. Now that other revenue sources in the U.S. are drying up, it may have been exploring this route.

The truth is, the company is already feeling the pain of U.S. sanctions with officials confirming that international sales are down 40% (according to media reports). And although domestic sales have accelerated, and could see the company through the short term emergency, the inability to include American technology would cripple the company and limit it to second rate offerings for sale in the domestic market. Until it is able to come up with alternatives of its own that is. If at all it is able to create suitable alternatives, it could be several years before such technology is exported for gain.

The Chinese government could step in as part of its trade deal, something the U.S. has said it will entertain. Or it may not, if it is willing to take the risk of Huawei, which is a huge company, somehow battle it out on its own.

Recommendations

National wireless communications stocks are hot right now, so you can take your pick of Verizon, GCI Liberty (NASDAQ:GLIBA) , Gogo (NASDAQ:GOGO) and T-Mobile U.S. (NASDAQ:TMUS) , all of which have a Zacks Rank #2 (Buy). Or you can pick Zacks #1-ranked United States Cellular Corp. (NYSE:USM) , or simply check out the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Verizon Communications Inc. (VZ): Free Stock Analysis Report

T-Mobile US, Inc. (TMUS): Free Stock Analysis Report

Gogo Inc. (GOGO): Free Stock Analysis Report

United States Cellular Corporation (USM): Free Stock Analysis Report

GCI Liberty, Inc. (GLIBA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.